Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3

SARS-CoV-2 Omicron variant has presented significant challenges to current antibodies and vaccines. Herein, we systematically compared the efficacy of 50 human monoclonal antibodies (mAbs), covering the seven identified epitope classes of the SARS-CoV-2 RBD, against Omicron sub-variants BA.1, BA.1.1...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Min, Wu, Lili, Zheng, Anqi, Xie, Yufeng, He, Qingwen, Rong, Xiaoyu, Han, Pu, Du, Pei, Han, Pengcheng, Zhang, Zengyuan, Zhao, Runchu, Jia, Yunfei, Li, Linjie, Bai, Bin, Hu, Ziliang, Hu, Shixiong, Niu, Sheng, Hu, Yu, Liu, Honghui, Liu, Bo, Cui, Kaige, Li, Weiwei, Zhao, Xin, Liu, Kefang, Qi, Jianxun, Wang, Qihui, Gao, George Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197780/
https://www.ncbi.nlm.nih.gov/pubmed/35777362
http://dx.doi.org/10.1016/j.immuni.2022.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197780/
https://www.ncbi.nlm.nih.gov/pubmed/35777362
http://dx.doi.org/10.1016/j.immuni.2022.06.005

Ejemplares similares